ICUI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ICUI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ICU Medical has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.
ICU Medical has ICU Medical Inc has a balanced import/export profile with manufacturing in multiple regions. The company has some pricing power and can mitigate tariff impacts through alternative suppliers. Historical tariff changes have had limited impact due to industry exemptions.
Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.
The company's exposure to international trade tariffs based on these criteria:
1. Global supply chain dependenciesBased on the research, GuruFocus believes ICU Medical might have Average Resilient.
For the Medical Instruments & Supplies subindustry, ICU Medical's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's Tariff Resilience Score distribution charts can be found below:
* The bar in red indicates where ICU Medical's Tariff Resilience Score falls into.
ICU Medical (NAS:ICUI) Tariff Resilience Score Explanation
The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:
Tariff Resilience Score | Resilience Level |
7 - 10 | Highly Resilient |
4 - 6 | Average Resilient |
0 - 3 | Highly Vulnerable |
Thank you for viewing the detailed overview of ICU Medical's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.
Christian B. Voigtlander | officer: Chief Operating Officer | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Elisha W Finney | director | C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304 |
David C. Greenberg | director | 951 CALLE AMANECER, SAN CLEMENTE CA 92887 |
Vivek Jain | director, officer: Chairman and CEO | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Daniel Woolson | officer: VP, GM-Infusion Capital | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Virginia Ruth Sanzone | officer: VP, General Counsel | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
George A Lopez | director, officer: Chairman, other: Chairman | C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Smiths Group International Holdings Ltd | 10 percent owner | C/O SMITHS GROUP PLC, 11-12 ST. JAMES'S SQUARE, 4TH FLOOR, LONDON X0 SW1Y 4LB |
Group Plc Smiths | 10 percent owner | 765 FINCHKEY ROAD, LONDON X0 00000 |
William Seeger | director | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Kolleen T Kennedy | director | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
Robert S Swinney | director | C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Laurie Hernandez | director | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Brian Michael Bonnell | officer: Chief Financial Officer | ICU MEDICAL INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Scott E Lamb | officer: Controller | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
From GuruFocus
By PRNewswire • 04-28-2025
By GuruFocus News • 05-09-2025
By GuruFocus News • 05-29-2025
By GuruFocus News • 05-07-2025
By Marketwired • 05-13-2025
By GuruFocus News • 05-01-2025
By Marketwired • 05-22-2025
By Marketwired • 05-08-2025
By GuruFocus News • 05-09-2025
By GuruFocus News • 05-08-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.